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Abstract
Introduction The pathogenesis of delayed cerebral ischemia
(DCI) after subarachnoid hemorrhage (SAH) is unclear. We
assessed whether DCI relates to focal or global cerebral
perfusion on admission and on follow-up imaging.
Materials and methods Twenty-seven SAH patients under-
went computed tomography (CT) perfusion (CTP) on
admission and at clinical deterioration or 1 week after admis-
sion in clinically stable patients. We compared global and
focal (least perfused territory) perfusion in patients with DCI
(n=12), clinically stable patients (n=7), and patients with
non-DCI-related deterioration (n=8).
Results Global cerebral blood flow (CBF) increased on
follow-up: 29% (95% confidence interval (CI) 15% to 43%)
in patients with DCI, 12% (95%CI −1% to 25%) in stable
patients, and 20% (95%CI 4% to 36%) in patients with non-
DCI-related deterioration. Focal CBF decreased in patients
with DCI, (−23%; 95%CI −58% to 12%) but increased in
patients with non-DCI-related deterioration (23%; 95%CI
−26% to 55%) and stable patients (7%; 95%CI −30% to 45%).
On follow-up, global CBF was lower in patients with DCI
(70.0 ml per 100 g/min) than in clinically stable patients (81.6;
difference 11.6; 95%CI 0.8 to 22.5 ml per 100 g/min) but
comparable to patients with non-DCI-related deterioration
(67.6; difference −2.4; 95%CI −11.9 to 7.2 ml per 100 g/min).
Focal CBF was lower in patients with DCI (30.7) than in
clinically stable patients (53.6; difference 22.9; 95%CI 5.1 to
40.6 ml per 100 g/min) and patients with non-DCI-related
deterioration (46.6; difference 15.9; 95%CI −2.6 to 28.4 ml
per 100 g/min)
Conclusion Our results suggest that DCI is more likely a
focal than a global process.
Keywords Subarachnoid hemorrhage . Brain ischemia .
CT perfusion . Cerebral autoregulation
Introduction
Delayed cerebral ischemia (DCI) is the most important
complication leading to poor outcome in patients who survive
the acute phase after subarachnoid hemorrhage (SAH) and in
whom the aneurysm is occluded [1]. The pathogenesis of DCI
is still unclear. Insight in the pathogenesis of DCI is
important for advances in preventive treatment.
In the development of DCI, a cerebral perfusion deficit
precedes the final infarction [2–4]. Whether the perfusion
deficit reverses or evolves into infarction depends on the
extent of the perfusion deficits and the autoregulation
capacity [5, 6]. The autoregulation mechanism is reported
to be altered or defect in patients who develop DCI [4, 7–9].
Whether the pathogenesis of DCI is mainly a focal or a
generalized process is unsettled [10]. Since treatment ap-
proaches for DCI are either systemic (e.g., triple H) or
focal (e.g., balloon dilatation of spastic vessels), the patho-
genesis of DCI and whether it has a focal or global
pathogenesis is of importance.
Besides DCI, SAH patients may also deteriorate from
other causes such as hydrocephalus or metabolic distur-
bance. To assess whether perfusion deficits are specific for
DCI or just a sign of deterioration in general, it is therefore
important to compare cerebral perfusion in patients with
DCI not only to that of clinically stable patients but also to
patients with non-DCI-related deterioration.
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Since CT is used for follow-up of patients after SAH in
most hospitals, CTP is a practical tool for clinical assessment
of both focal and global cerebral perfusion. CTP allows quan-
titative measurements of cerebral perfusion on tissue level and
provides information on cerebral blood volume (CBV),
cerebral blood flow (CBF), and mean transit time (MTT).
The aim of this study was to assess whether DCI relates to
focal or global cerebral perfusion on admission and on follow-
up imaging and to compare global and focal perfusion in
patients with DCI with that in clinically stable patients and in




We prospectively studied a consecutive series of patients
admitted to the University Medical Center Utrecht. If SAH
was established on a noncontrast CT scan (NCCT), we im-
mediately proceeded to CTP and CT angiography (CTA).
Patients were included for the current study if the CTP scan
was performed within 72 h after SAH and if they underwent a
follow-up CTP scan within 14 days after SAH. Patients with
SAH from causes other than a ruptured aneurysm, patients
younger than 18 years of age, and patients with rebleeding
during follow-up were excluded from the current study. For all
patients, the clinical status on admission was assessed by
means of the World Federation of Neurological Surgeons
(WFNS) scale. [11] All patients were treated according to a
standardized protocol that consisted of absolute bed rest until
aneurysm treatment, administration of nimodipine, cessation
of antihypertensive medication, and intravenous administra-
tion of fluid aiming for normovolemia. The admission CTP
scan is standard clinical practice in our hospital. Informed
consent for the study protocol was obtained from all patients.
The study was approved by the ethics committee of the
University Medical Center Utrecht.
Imaging technique
In our hospital, all patients with SAH routinely undergo
NCCT, CTP, and CTA on admission. The CTA scan is used to
diagnose and localize the ruptured aneurysm. The CTP scan is
performed prior to CTA and replaces the timing scan for the
CTA. All imaging studies were performed on a 16-slice spiral
CT scanner (Philips M ×8000 LDT, Best, the Netherlands).
CTP source data were derived from sequential scans covering
a slab of 2.4-cm thickness selected 3 cm above the sella turcica
and angulated parallel to the meato-orbital line to contain the
upper parts of the lateral ventricles and the basal ganglia. Forty
milliliter of nonionic contrast agent (iopromide, Ultravist,
300 mg iodine per milliliter, Schering, Berlin, Germany) was
injected into the cubital vein (18 gauge needle) at a rate of
5 ml/s followed by a 40ml saline flush at a rate of 5 ml/s using
a dual-power injector (Stellant Dual CT injector, Medrad
Europe BV, Beek, the Netherlands). The following parameters
were used: 90 kVp, 150 mAs, 8×3-mm collimation, 512×512
matrix, 200 mm field of view, one image per 2 s during 60 s
(total 30 images), UB filter, and standard resolution.
CTP measurements and data processing
Follow-up NCCT and CTP scans were performed at time of
the clinical deterioration. In patients who remained clini-
cally stable, a scan was planned about 1 week after admis-
sion. CTP scans were reconstructed at 6-mm contiguous
axial images. Data were transferred to a Philips workstation
for postprocessing. The quantitative cerebral perfusion
measurements on CTP were based on temporal changes in
signal intensity during the first pass of a bolus of an iodi-
nated contrast agent. An arterial input function (AIF) and a
venous output function (VOF; to correct for the partial
volume effects of the AIF) were used in the calculations.
The optimal AIF and VOF (voxels with the largest area
under the curve (AUC) and an early arrival time of the
contrast agent) were selected within the stack of 6-mm
contiguous axial slices.
CBV was calculated as the ratio of the AUC of the first
passage of the contrast agent through the tissue (AUCtissue)
to that of the AUC of the AIF (AUCAIF) with a correction
factor H to account for the difference in the hematocrit in
small versus large vessels: CBV=H×AUCtissue/AUCAIF.
The MTT, the average time taken by the blood to cross the
capillary network, is calculated by means of deconvolution
analysis [12]. The calculation of the CBF is based upon the
“central volume principle,” which states that the CBF is
equal to the ratio of CBV and MTT: CBF=CBV/MTT
CTP measurements were performed on both the admis-
sion and follow-up CTP scan. Eight regions of interest
(ROIs) were drawn in the cortical gray matter or basal
ganglia, bilateral in the peripheral flow territories of the
anterior and middle cerebral artery (ACA and MCA,
respectively) and bilateral in the deep flow territories of
the ACA and MCA as presented in Fig. 1 and described in
a previous article [13]. The ROIs were drawn by one of two
observers blinded for the clinical condition of the patient
(MR, IvdS). CTP measurements in the flow territory of the
posterior cerebral artery were not included in this study.
DCI and clinical deterioration
Patients were divided into three groups according to their
clinical course: (1) patients with clinical deterioration from
DCI, (2) clinically stable patients, and (3) patients with
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deterioration from hydrocephalus or metabolic disturbances
(non-DCI-related deterioration).
The occurrence of DCI was assessed by a neurologist
blinded for the CTP results. DCI was defined as a clinical
deterioration (i.e., new focal deficit, decrease in conscious-
ness, or both) lasting 2 h or longer with no evidence for re-
bleeding or hydrocephalus on CT and no other medical
causes, such as infections or metabolic disturbances, and with
or without hypodensity on CT. Non-DCI-related deterioration
was defined as a decrease in Glasgow coma score of two
points with the finding of hydrocephalus (bicaudatus index
larger than 1) or other medical causes affecting the overall
brain such as infection or metabolic disturbances. Infection
was defined as: fever– leukocytosis–increased C-reactive
protein along with clinical picture of infection for which
antibiotic treatment was indicated.
Metabolic disturbances were defined as: hyponatremia
or hypernatremia (<125 or >155 mmol/l), hypomagnese-
mia (< 0.6 mmol/l), ionized hypercalcemia (>1.3 mmol/l).
Patients with other causes for clinical deterioration such as
cardiovascular complications or rebleeding were excluded.
Analysis
Global cerebral perfusion
First, the changes in global cerebral perfusion between
admission and follow-up scan were compared between the
three patient groups. For global cerebral perfusion on the
admission scan, mean perfusion values of all eight ROIs per
patient were calculated. On the follow-up scan, mean
perfusion values of seven ROIs, excluding the least perfused
ROI (lowest quantitative values for CBF and CBVand highest
quantitative values for MTT per patient), per patient were
calculated. The least perfused ROI was excluded since
extreme perfusion values (as in brain tissue with intracerebral
hematoma or infarcted tissue) would influence global brain
perfusion and thereby potentially bias the results. Mean
perfusion values per patient group were charted.
We compared global cerebral perfusion on the follow-up
scan between the different patient groups by calculating
differences and 95% confidence intervals for patients with
DCI versus clinically stable patients and versus patients with
non-DCI-related deterioration.
Focal cerebral perfusion
Second, we studied the changes in focal cerebral perfusion
between admission and follow-up scan for the three patient
groups. Per scan, we selected the ROI with the least fa-
vorable perfusion. The least perfused flow territory on the
initial and follow-up scan was not per definition located in
the same flow territories. Mean focal perfusion values per
patient group were calculated and charted.
We also compared differences in focal cerebral perfusion
on follow-up for patients with DCI versus clinically stable
patients and patients with non-DCI-related deterioration in a
quantitative and semiquantitative manner. For the quantita-
tive approach, again, ROIs with the least favorable perfusion
values were selected. For the semiquantitative approach, we
compared asymmetry in flow territories of contralateral
hemispheres. We calculated ratios for CBV and CBF and
differences for MTT for corresponding ROIs of both hemi-
spheres. Per patient, the ROIs with the lowest CBVand CBF
ratio and the largest MTT difference (reflecting the largest
asymmetry in perfusion between both hemispheres) were
selected.
For quantitative perfusion values, we calculated differences
and 95% confidence intervals of the differences for patients
with DCI versus clinically stable patients and versus patients
with non-DCI-related deterioration. Semiquantitative values
of the three patient groups (ratios and differences) were
compared by means of the nonparametric Wilcoxon ranking
score. A p value less than 0.05 was considered statistically
significant.
Results
Thirty-one patients met our inclusion criteria; however, in
four patients, the follow-up scan was of too poor a quality
due to movement of the patient (three patients) or due to
inaccurate timing of the contrast administration (one patient)
to allow analysis; thus, these four patients were excluded. In
none of the included patients adverse side effects, such as
Fig. 1 Eight regions of interest in the cortical gray matter or basal
ganglia for perfusion measurement
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contrast allergy, occurred. Of the 27 included patients, 12
developed DCI, seven remained clinically stable patients,
and eight patients developed a clinical deterioration from
hydrocephalus or metabolic derangement. The patient char-
acteristics and time of the admission and follow-up scans of
the 27 included patients are summarized in Table 1.
Global cerebral perfusion
Changes in global cerebral perfusion between admission and
follow-up are presented in Fig. 2. Patients with DCI had the
lowest global cerebral CBF and CBV values on admission
which improved on the follow-up scan. CBF increased with
29%, CBV increased with 10%, and MTT decreased with
8%. Clinically stable patients had the highest CBF and CBV
values and lowest MTT values on admission. On follow-up,
CBF increased with 12%, CBV did not change, and MTT
decreased with 9%. Patients with non-DCI-related clinical
deterioration had CBF values comparable to patients with
DCI. CBF increased with 20%, CBV increased with 2%, and
MTT decreased with 37%. The follow-up global perfusion
showed less favorable perfusion values in patients with DCI
compared to clinically stable patients (CBF 14% lower, CBV
8% lower, MTT 13% higher) and was equal to (CBV) or
differed minimally (CBF 4% higher, MTT 7% higher) from
patients with non-DCI-related deterioration. (Table 2)
Focal cerebral perfusion
Changes in focal cerebral perfusion (least perfused flow
territories) are shown in Fig. 2. Patients with DCI showed a
decrease in focal CBF of 23% and CBV of 18% and an
increase in focal cerebral MTT of 58%. Clinically stable
patients had an increase in focal CBF of 7%, CBV of 12%,
and a decrease in focal cerebral MTT of 4%. Patients with
non-DCI-related clinical deterioration had an increasing CBF
of 23%, stable focal CBV, and decreasing MTT of 48%. On
follow-up, focal perfusion values were least favorable for
patients with DCI; compared to clinically stable patients,
CBF was 43% lower, CBV 27% lower, and MTT 90%
higher and compared to patients with non-DCI-related
deterioration CBF was 34% lower, CBV was 17% lower,
and MTT 80% higher. Differences were statistically signifi-
cant for CBVand CBF values in patients with DCI compared
to clinically stable patients. (Table 3)
When comparing perfusion asymmetry (semiquantitative
approach), patients with DCI showed more asymmetry in all
perfusion values compared to both other patient groups.
Differences in asymmetry were statistically significant except
for asymmetry in CBF compared to clinically stable patients.
(Table 3)
Discussion
Global cerebral perfusion on follow-up was less favorable in
patients with DCI compared to clinically stable patients but
was equal to(CBV) or differed marginally (CBF and MTT)
from patients with non-DCI-related deterioration. Contrary to
global perfusion, focal cerebral perfusion decreased between
admission and follow-up scan in patients with DCI but
increased in clinically stable patients and patients with non-
DCI-related deterioration. In addition to decreased focal
perfusion, patients with DCI had significantly more asymme-
try in perfusion on follow-up compared to the other two
patient groups. This indicates that, in the development of DCI,
focal processes play a role. In patients with non-DCI-related
deterioration, focal and global cerebral perfusion increased on
follow-up, but global cerebral perfusion remained lower than
in clinically stable patients. This indicates that not focal but
mainly global processes are involved in the development of
non-DCI-related clinical deterioration.
For a better understanding of the pathogenesis of DCI, we
shall first discuss the acute phase after SAH in which several








Number of women (%) 8 (67%) 7 (100%) 6 (75%) 21 (78%)
Mean age in years (range) 59 (38–84) 49 (36–63) 62 (46–73) 57 (36- 84)
WFNS grade (number of patients)
1 1 (8%) 5 (71%) 3 (38%) 9 (33%)
2 4 (33%) 1 (14%) 2 (25%) 7 (26%)
3 2 (17%) 0 0 2 (7%)
4 2 (17%) 1 (14%) 0 3 (11%)
5 3 (25%) 0 3 (38%) 6 (22%)
Mean days after SAH for admission
scan (range 0–3 days)
0.7 1.1 0.5 0.7
Mean days after SAH for follow-up
scan (range 2–14 days)
7.3 9.1 6.8 7.6
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pathophysiologic and compensatory mechanisms are initiat-
ed. In the hyperacute stage after SAH, intracranial pressure
raises and cerebral perfusion pressure drops with conse-
quently a decrease in CBF. [14, 15] In the compensation for
this initial perfusion drop, cerebral autoregulation mecha-
nisms play a role. If cerebral perfusion is compromised,
cerebral autoregulation causes cerebral vasodilatation,
reflected by an increased CBV. [16] If cerebral perfusion





































































Fig. 2 Global (fat symbols) and
focal (open symbols) perfusion
on admission and follow-up in
clinically stable patients (circle),
patients with non-DCI-related
deterioration (triangle), and
patients with DCI (squares).
a Changes in cerebral blood
flow (CBF; milliliter per
100 g/min), b changes in
cerebral blood volume (CBV;
milliliter per 100 g), and
c changes in mean transit time
(MTT; seconds)
Table 2 Follow-up global cerebral perfusion in patients with DCI, clinically stable patients, and patients with non-DCI-related deterioration.
Clinically stable compared to DCI Deteriorating without DCI compared to DCI
Perfusion parameter (mean) DCI Clinically stable Difference (95% CI) Deteriorating without DCI Difference (95% CI)
CBF (milliliter per 100 g/min) 70.0 81.6 11.6 (0.8 to 22.5) 67.6 −2.4 (−11.9 to 7.2)
CBV (milliliter per 100 g) 4.5 4.9 0.4 (−0.01 to 0.8) 4.5 −0.02 (−0.5 to 0.4)
MTT (second) 4.4 3.9 −0.5 (−1.2 to 0.1) 4.1 −0.3 (−0.9 to 0.3)
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decreases further and the ability of vessels to dilate is ex-
hausted, the CBF starts to decrease. The brain can com-
pensate for this by increasing the extraction of oxygen from
the blood. This is enabled by a prolongedMTTsince the slow
flow of blood results in greater extraction of oxygen. [16]
In the present study, patients were scanned on admission in
the subacute phase after SAH. Clinically stable patients had
initially highest global brain CBF values compared to patients
with clinical deterioration and showed an increasing CBV,
which represents adequate autoregulation. Patients with DCI
had initially lowest global brain CBF values in combination
with lowest CBV values and an only slightly raised MTT
indicating that cerebral autoregulation was inadequate. These
reported changes in cerebral perfusion are beyond chance
since statistically significant differences in focal cerebral
perfusion with corresponding trends in global cerebral
perfusion are observed, despite the relatively small number
of patients included in each group. Also, our results
correspond with the results in two articles measuring cerebral
perfusion in the first 3 weeks after SAH. [17, 18] The concept
of impaired autoregulation mechanisms on admission in
patients who later develop DCI has also been described in
other articles. [4, 7, 9, 13, 15, 19]
This study also showed that CTP is a practical and useful
tool to compare perfusion on admission and during follow-up
in patients with SAH since in 87% of patients a good quality
admission and follow-up scan was obtained and no side
effects of the CT scanning with contrast occurred. Often,
transcranial Doppler (TCD) monitoring is used for follow-up
monitoring in patients with SAH for the presence of
vasospasm. TCD, however, cannot be used to quantify CBF
at the tissue level and sensitivity is high for the middle cerebral
artery but low for the other vessels. [20] Other techniques to
measure brain perfusion include positron emission tomogra-
phy, single-photon emission tomography, xenon-enhanced
CT, and perfusion magnetic resonance imaging. [21]
However, these techniques have limited clinical access, in
particular for patients who are restless or ventilated. In
patients with neurological deterioration, it is standard clinical
practice to perform an NCCT scan for detection or exclusion
of hydrocephalus, rebleed, or infarction. CTP can be
performed directly after this NCCT scan and can serve for
the timing scan for CTA. The postprocessing and measure-
ments of CTP could be performed within 5 min. Therefore,
CTP is practical in the clinical setting.
Controversies exist regarding the quantitative perfusion
values of CTP although CTP has been validated many times
in animal and human models. [22] Our quantitative
perfusion values were within the range described by other
groups. [17, 23] Also, our semiquantitative analyses were
in the same line as the quantitative findings, which further
supports the validity of our quantitative measures.
A disadvantage of measuring cerebral perfusion by means
of CTP is the limited brain volume included in the perfusion
slab. In this study, the perfusion slab measured 2.4 cm and
thus represents only a certain proportion of the total brain
parenchyma. Since this slice was located on the level of the
basal ganglia, we think that the brain structures most prone to
DCI were included in the slab. However, we might have
missed locations with more severe perfusion deficits in other
parts of the brain. Also, we measured perfusion in predefined
ROIs. Again, more severe perfusion deficits might have been
located outside or partly inside the ROI. This limitation
accounts for all patients. If this problem would have biased
our results, it would be towards less relation and thus stronger
relations are expected when measuring the most severe
perfusion deficits in whole-brain volumes. By using CT
scanners with increasing detector rows, the problem of limited
scan volume will be resolved.
In the present study, we investigated differences in global
and focal cerebral perfusion in patient groups to obtain more
knowledge on the pathogenesis of DCI. Subsequently, this
Table 3 Follow-up focal cerebral perfusion: least perfused flow territories and largest perfusion asymmetry.
Perfusion parameter Clinically stable compared to DCI Deteriorating without DCI compared to DCI







Lowest CBF (milliliter per 100 g/min) 30.7 53.6 22.9 (5.1 to 40.6) 46.6 15.9 (−2.6 to 28.4)
Lowest CBV (milliliter per 100 g) 2.7 3.8 1.03 (0.2 to 1.9) 3.3 0.57 (−0.3 to 1.4)
Highest MTT (second) 9.5 5.0 −4.52 (−9.7 to 0.7) 5.3 −4.22 (−9.4 to 1.0)
Semiquantitativec (median)
Lowest CBF (milliliter per 100 g/min) 0.53 0.77 0.07 0.78 0.05
Lowest CBV (milliliter per 100 g) 0.65 0.85 0.03 0.78 0.05
Highest MTT (second) 1.77 0.73 0.05 0.70 0.009
a Difference (95%CI) for quantitative; Wilcoxon ranking score for semiquantitative
b Quantitative: mean values of the least perfused flow territories
c Semiquantitative: ratio’s of CBV and CBF and difference of MTT corresponding to the flow territory with the largest asymmetry
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knowledge can be used to study individual patient data and
determine what diagnostic and prognostic information can be
derived from their CTP scan results. Future research could
elaborate the value of individual measurements.
Clinically stable patients were younger than both groups of
patients with clinical deterioration. Cerebral perfusion
decreases with age. The average annual overall decrease in
normal gray matter is around 0.37% to 0.45%. [24] Even if
0.45% decrease per year is taken into account, the difference
in age cannot explain the discrepancy in perfusion between
the three patient groups. Patients later developing DCI or
non-DCI-related clinical deterioration had more severe
WFNS grades on admission than clinically stable patients.
Clinical condition is considered as an expression of cerebral
perfusion. Research provided evidence for the predictive
value of clinical condition on admission in the development
of DCI. [25] In the present study, we studied global and focal
cerebral perfusion after SAH and its relation with DCI and
not the predictive value of cerebral perfusion on admission in
the development of DCI. Therefore, clinical condition is not
a biasing factor for the relation between global and focal
cerebral perfusion and the development of DCI.
For current medical treatment for reversing DCI, a
combination of hypertension, hypervolemia, and hemodilu-
tion (triple H), or other treatment as for example balloon
angioplasty, efficacy has not been proven by means of
randomized clinical trials. [26, 27] Therefore, monitoring
effects of these treatment strategies is of importance. This
study shows that CTP offers a feasible method in patients
with SAH for monitoring of cerebral perfusion and allows
comparison of perfusion values between two scans. There-
fore, CTP might be useful to study the effects of different
treatment strategies for DCI on cerebral perfusion and the
occurrence of DCI.
Conclusion
The present study demonstrates that CTP is a suitable tool to
compare cerebral perfusion on admission and follow-up. All
patients had an improved global perfusion during follow-up.
Focal perfusion however decreased on follow-up in patients
with DCI but not in patients with non-DCI-related deterio-
ration or clinically stable patients, and patients with DCI had
least favorable focal perfusion values on follow-up. This
suggests that DCI is more likely a focal than a global process.
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